These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. American Society of Clinical Oncology endorsement of the Cancer Care Ontario Practice Guideline on nonhormonal therapy for men with metastatic hormone-refractory (castration-resistant) prostate cancer. Basch EM; Somerfield MR; Beer TM; Carducci MA; Higano CS; Hussain MH; Scher HI; J Clin Oncol; 2007 Nov; 25(33):5313-8. PubMed ID: 17925542 [TBL] [Abstract][Full Text] [Related]
24. Erythropoietin use in oncology: a summary of the evidence and practice guidelines comparing efforts of the Cochrane Review group and Blue Cross/Blue Shield to set up the ASCO/ASH guidelines. Djulbegovic B Best Pract Res Clin Haematol; 2005; 18(3):455-66. PubMed ID: 15792920 [TBL] [Abstract][Full Text] [Related]
25. ASCO Clinical Practice Guideline for the Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer: Guideline Summary. J Oncol Pract; 2006 Sep; 2(5):258-261. PubMed ID: 29447032 [No Abstract] [Full Text] [Related]
26. Application of the 2013 ASCO/CAP guideline and the SISH technique for HER2 testing of breast cancer selects more patients for anti-HER2 treatment. Polónia A; Leitão D; Schmitt F Virchows Arch; 2016 Apr; 468(4):417-23. PubMed ID: 26754674 [TBL] [Abstract][Full Text] [Related]
27. The updated ASCO/CAP guideline recommendations for HER2 testing in the management of invasive breast cancer: a critical review of their implications for routine practice. Rakha EA; Starczynski J; Lee AH; Ellis IO Histopathology; 2014 Apr; 64(5):609-15. PubMed ID: 24382093 [TBL] [Abstract][Full Text] [Related]
28. Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology-Cancer Care Ontario Focused Guideline Update. Van Poznak C; Somerfield MR; Barlow WE; Biermann JS; Bosserman LD; Clemons MJ; Dhesy-Thind SK; Dillmon MS; Eisen A; Frank ES; Jagsi R; Jimenez R; Theriault RL; Vandenberg TA; Yee GC; Moy B J Clin Oncol; 2017 Dec; 35(35):3978-3986. PubMed ID: 29035643 [TBL] [Abstract][Full Text] [Related]
29. Use of hematopoietic colony-stimulating factors: comparison of the 1994 and 1997 American Society of Clinical Oncology surveys regarding ASCO clinical practice guidelines. Health Services Research Committee of the American Society of Clinical Oncology. Bennett CL; Weeks JA; Somerfield MR; Feinglass J; Smith TJ J Clin Oncol; 1999 Nov; 17(11):3676-81. PubMed ID: 10550166 [TBL] [Abstract][Full Text] [Related]
30. ASCO Recommendations on Fertility Preservation in Cancer Patients: Guideline Summary. J Oncol Pract; 2006 May; 2(3):143-146. PubMed ID: 29443586 [No Abstract] [Full Text] [Related]
31. Are Physicians Choosing Wisely When Imaging for Distant Metastases in Women With Operable Breast Cancer? Simos D; Hutton B; Clemons M J Oncol Pract; 2015 Jan; 11(1):62-8. PubMed ID: 25392522 [TBL] [Abstract][Full Text] [Related]
32. Antiemetics: American Society of Clinical Oncology Focused Guideline Update. Hesketh PJ; Bohlke K; Lyman GH; Basch E; Chesney M; Clark-Snow RA; Danso MA; Jordan K; Somerfield MR; Kris MG; J Clin Oncol; 2016 Feb; 34(4):381-6. PubMed ID: 26527784 [TBL] [Abstract][Full Text] [Related]
36. Use of 5-α-Reductase Inhibitors for Prostate Cancer Chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline Summary. J Oncol Pract; 2009 May; 5(3):127-129. PubMed ID: 29452038 [TBL] [Abstract][Full Text] [Related]
37. Management and Care of Women With Invasive Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Clinical Practice Guideline. Chuang LT; Temin S; Camacho R; Dueñas-Gonzalez A; Feldman S; Gultekin M; Gupta V; Horton S; Jacob G; Kidd EA; Lishimpi K; Nakisige C; Nam JH; Ngan HYS; Small W; Thomas G; Berek JS J Glob Oncol; 2016 Oct; 2(5):311-340. PubMed ID: 28717717 [TBL] [Abstract][Full Text] [Related]
38. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. ; Ferraris VA; Brown JR; Despotis GJ; Hammon JW; Reece TB; Saha SP; Song HK; Clough ER; ; Shore-Lesserson LJ; Goodnough LT; Mazer CD; Shander A; Stafford-Smith M; Waters J; ; Baker RA; Dickinson TA; FitzGerald DJ; Likosky DS; Shann KG Ann Thorac Surg; 2011 Mar; 91(3):944-82. PubMed ID: 21353044 [TBL] [Abstract][Full Text] [Related]
39. Assessment of dual-probe Her-2 fluorescent in situ hybridization in breast cancer by the 2013 ASCO/CAP guidelines produces more equivocal results than that by the 2007 ASCO/CAP guidelines. Qian XL; Wen HY; Yang YL; Gu F; Guo XJ; Liu FF; Zhang L; Zhang XM; Fu L Breast Cancer Res Treat; 2016 Aug; 159(1):31-9. PubMed ID: 27455837 [TBL] [Abstract][Full Text] [Related]
40. ASCO 2006 Update of the Breast Cancer Follow-Up and Management Guideline in the Adjuvant Setting. J Oncol Pract; 2006 Nov; 2(6):317-318. PubMed ID: 29447564 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]